作者认为目前对红霉素的使用过少,应重新予以评价,理由是:①对红霉素耐药性的恐惧过于夸大;②比红霉素更优越的更新的抗菌素十分少;③大多数红霉素类药物使用安全,明显的毒性仅见于红霉素的衍生物红霉素酯,某些患者使用该药超过2周时可产生肝脏损害和黄疸(大多数在停药后恢复正常),而红霉素基质本身并无毒性,红霉素化合物(红霉素硬脂酸盐和琥珀乙基红霉素)的使用也很安全,唯一的副作用是相当轻的胃肠道障碍。25年来尚无红霉素引 The author believes that the current use of erythromycin is too small, should be re-evaluated on the grounds that: ① the fear of erythromycin resistance is too exaggerated; ② more superior than the updated erythromycin antibiotic is very small; ③ most Erythromycin safe, obvious toxicity only seen in erythromycin derivatives erythromycin ester, some patients using the drug for more than 2 weeks can produce liver damage and jaundice (most returned to normal after withdrawal) , While the erythromycin matrix itself is nontoxic. The use of erythromycin compounds (erythromycin stearate and amber ethyl erythromycin) is also safe, with the only side effect of being a fairly mild gastrointestinal disorder. 25 years no erythromycin cited